|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
JPS5733175A
(en)
|
1980-07-31 |
1982-02-23 |
Mitsubishi Electric Corp |
Transmitter for signal of elevator
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
JPS607193A
(ja)
|
1983-06-25 |
1985-01-14 |
古河電気工業株式会社 |
回路基板用半田付炉
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US4966852A
(en)
|
1987-07-23 |
1990-10-30 |
Monsanto Company |
DNA clone of human tissue factor inhibitor
|
|
IL87171A
(en)
|
1987-11-23 |
1995-08-31 |
Monsanto Co |
cDNA of human tissue factor inhibitor
|
|
US5663143A
(en)
|
1988-09-02 |
1997-09-02 |
Dyax Corp. |
Engineered human-derived kunitz domains that inhibit human neutrophil elastase
|
|
US5219994A
(en)
|
1988-11-08 |
1993-06-15 |
W. Alton Jones Cell Science Center, Inc. |
Inhibitor of tissue factor activity
|
|
US5466468A
(en)
|
1990-04-03 |
1995-11-14 |
Ciba-Geigy Corporation |
Parenterally administrable liposome formulation comprising synthetic lipids
|
|
DK146190D0
(da)
|
1990-06-15 |
1990-06-15 |
Novo Nordisk As |
Hidtil ukendte forbindelser
|
|
US5622988A
(en)
|
1990-06-15 |
1997-04-22 |
Novo Nordisk A/S |
Use of a low molecular weight metabolite from fungus for reducing prolonged coagulation time
|
|
US5849703A
(en)
|
1990-08-27 |
1998-12-15 |
G. D. Searle & Co. |
Pre-formed anticoagulant heparin/TFPI complexes
|
|
DK261490D0
(da)
|
1990-10-31 |
1990-10-31 |
Novo Nordisk As |
New pharmaceutical compound
|
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
JPH04252954A
(ja)
|
1991-01-29 |
1992-09-08 |
Asahi Chem Ind Co Ltd |
タンパクの測定方法、試薬及びキット
|
|
US5833982A
(en)
|
1991-02-28 |
1998-11-10 |
Zymogenetics, Inc. |
Modified factor VII
|
|
US5997864A
(en)
|
1995-06-07 |
1999-12-07 |
Novo Nordisk A/S |
Modified factor VII
|
|
JPH067193A
(ja)
|
1991-11-29 |
1994-01-18 |
Teijin Ltd |
モノクローナル抗体
|
|
EP0539975A1
(en)
|
1991-10-31 |
1993-05-05 |
Teijin Limited |
Method for immunological assay of free lipoprotein-associated coagulation inhibitor (LACI) and kit therefor
|
|
IL104314A0
(en)
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them
|
|
IL104327A0
(en)
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Variant of human kunitz-type protease inhibitor
|
|
IL104326A0
(en)
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Variant of human kunitz-type protease inhibitor
|
|
IL104325A
(en)
|
1992-01-07 |
2000-10-31 |
Novo Nordisk As |
Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above
|
|
IL104324A0
(en)
|
1992-01-07 |
1993-05-13 |
Novo Nordisk As |
Variant of human kunitz-type protease inhibitor
|
|
EP0651655A4
(en)
|
1992-07-24 |
1996-05-29 |
Oklahoma Med Res Found |
REDUCTION OF MICROVASCULAR BLEEDING DURING SURGERY BY BLOCKING PROTEIN C ACTIVATION
|
|
JPH06153985A
(ja)
|
1992-11-16 |
1994-06-03 |
Teijin Ltd |
モノクローナル抗体
|
|
NZ262679A
(en)
|
1993-02-22 |
1997-08-22 |
Vivorx Pharmaceuticals Inc |
Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
|
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
CA2170030A1
(en)
|
1993-09-14 |
1995-03-23 |
Robert A. Lazarus |
Pharmaceutical compositions containing ecotin and homologs thereof
|
|
US5455338A
(en)
|
1993-11-05 |
1995-10-03 |
Zymogenetics, Inc. |
DNA encoding novel human kunitz-type inhibitors and methods relating thereto
|
|
ATE277081T1
(de)
|
1994-01-11 |
2004-10-15 |
Dyax Corp |
Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten
|
|
US5902582A
(en)
|
1995-09-05 |
1999-05-11 |
Chiron Corporation |
Use of TFPI inhibitor for treatment of cancer
|
|
JP3681206B2
(ja)
|
1995-12-26 |
2005-08-10 |
株式会社三菱化学ヤトロン |
抗ファクターＸａ・ティシュファクターパスウェイインヒビター複合体モノクローナル抗体及びその使用
|
|
JP2001504709A
(ja)
|
1997-01-31 |
2001-04-10 |
ヒューマン ジノーム サイエンシーズ，インコーポレイテッド |
組織因子経路インヒビター３
|
|
US20050032690A1
(en)
|
1997-09-10 |
2005-02-10 |
Rojkjaer Lisa Payne |
Factor VII polypeptides for preventing formation of inhibitors in subjects with haemophilia
|
|
CA2320429C
(en)
|
1998-02-18 |
2011-04-19 |
Harbor-Ucla Research And Education Institute |
Antimicrobial peptides and derived metapeptides
|
|
JP2000128803A
(ja)
|
1998-10-19 |
2000-05-09 |
Shionogi & Co Ltd |
ティッシュ・ファクター・パスウェイ・インヒビター−２抗体
|
|
KR20020042622A
(ko)
|
1999-07-23 |
2002-06-05 |
코애귤레이션 다이어그노스틱스, 인크. |
전혈내 응고 인자 활성을 측정하는 방법
|
|
US6180607B1
(en)
|
1999-08-05 |
2001-01-30 |
Christopher Davies |
Protein having proteinase inhibitor activity
|
|
US6458387B1
(en)
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
CA2388517A1
(en)
|
1999-11-16 |
2001-05-25 |
The General Hospital Corporation |
Compositions and methods for regulating tumor-associated antigen expression
|
|
US6821775B1
(en)
|
2000-02-11 |
2004-11-23 |
Genvec, Inc. |
Viral vector encoding pigment epithelium-derived factor
|
|
US7015194B2
(en)
|
2000-05-10 |
2006-03-21 |
Novo Nordisk A/S |
Pharmaceutical composition comprising factor VIIa and anti-TFPI
|
|
JP2004505016A
(ja)
|
2000-05-10 |
2004-02-19 |
ノボ ノルディスク アクティーゼルスカブ |
第ＶＩＩａ因子及び第ＸＩＩＩ因子を含んで成る医薬組成物
|
|
ATE389416T1
(de)
|
2000-05-16 |
2008-04-15 |
Genentech Inc |
Behandlung von knorpelerkrankungen
|
|
WO2002033089A2
(en)
|
2000-10-05 |
2002-04-25 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Ixodes scapularis tissue factor pathway inhibitor
|
|
ATE430558T1
(de)
|
2000-10-27 |
2009-05-15 |
Baxter Healthcare Sa |
Herstellung von mikrokügelchen
|
|
AU2002354846B2
(en)
|
2001-07-20 |
2007-08-02 |
Novo Nordisk Health Care Ag |
Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
|
|
US20030040480A1
(en)
|
2001-07-20 |
2003-02-27 |
Rasmus Rojkjaer |
Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
|
|
US20080026068A1
(en)
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
|
US20030064033A1
(en)
|
2001-08-16 |
2003-04-03 |
Brown Larry R. |
Propellant-based microparticle formulations
|
|
WO2003028840A2
(en)
|
2001-09-27 |
2003-04-10 |
Board Of Regents, The University Of Texas System |
Combined compositions and methods for tumor vasculature coagulation and treatment
|
|
CN1176943C
(zh)
*
|
2001-10-08 |
2004-11-24 |
复旦大学 |
新型重组人组织因子途径抑制物活性肽及其制备方法
|
|
JP2005510513A
(ja)
|
2001-11-09 |
2005-04-21 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
Ｖｉｉ因子ポリペプチドおよびｔａｆｉポリペプチドを含む薬学的組成物
|
|
US7291587B2
(en)
|
2001-11-09 |
2007-11-06 |
Novo Nordisk Healthcare A/G |
Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides
|
|
US20050214836A1
(en)
|
2002-08-30 |
2005-09-29 |
Oncotherapy Science, Inc. |
Method of diagnosing ovarian endometriosis
|
|
US8809504B2
(en)
|
2002-09-03 |
2014-08-19 |
Vit Lauermann |
Inhibitor which is deactivatable by a reagent produced by a target cell
|
|
EP1403638A1
(en)
|
2002-09-25 |
2004-03-31 |
Mondobiotech SA |
Molecular methods for diagnosing interstitial lung diseases
|
|
DK1587907T3
(da)
|
2003-01-07 |
2011-04-04 |
Dyax Corp |
Kunitz-domænebibliotek
|
|
EP1620567A1
(en)
|
2003-04-15 |
2006-02-01 |
Hans-Jürgen Thiesen |
Method for diagnosing rheumatoid arthritis or osteoarthritis
|
|
US20070092452A1
(en)
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
|
BRPI0412735A
(pt)
|
2003-07-18 |
2006-09-26 |
Baxter Int |
métodos para a fabricação, uso e composição de partìculas esféricas pequenas preparadas mediante a separação de fase controlada
|
|
US20050142205A1
(en)
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
|
JP2007508240A
(ja)
|
2003-07-22 |
2007-04-05 |
バクスター・インターナショナル・インコーポレイテッド |
低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
|
|
EP1664291B1
(en)
|
2003-09-09 |
2012-02-29 |
Novo Nordisk Health Care AG |
Coagulation factor vii polypeptides
|
|
ES2381110T3
(es)
|
2003-09-09 |
2012-05-23 |
Novo Nordisk Health Care Ag |
Polipéptidos de factor VII de coagulación
|
|
JP4603548B2
(ja)
|
2003-09-24 |
2010-12-22 |
オンコセラピー・サイエンス株式会社 |
Ｔｆｐｉ−２タンパク質を用いた卵巣子宮内膜症の診断法
|
|
PL1667743T3
(pl)
|
2003-09-29 |
2008-06-30 |
Hemoteq Ag |
Biokompatybilne, biostabilne pokrycie powierzchni medycznych
|
|
US20090232866A1
(en)
|
2003-10-07 |
2009-09-17 |
Mariann Pavone-Gyongyosi |
Oligopeptides as coating material for medical products
|
|
RU2006115783A
(ru)
|
2003-11-20 |
2007-12-27 |
Ново Нордиск Хелс Кеа Аг (Ch) |
Терапевтическое применение фактора xi
|
|
US20050181978A1
(en)
|
2003-11-20 |
2005-08-18 |
Rasmus Rojkjaer |
Therapeutic use of factor XI
|
|
KR101337320B1
(ko)
|
2003-11-20 |
2013-12-06 |
사노피 파스퇴르 인크 |
백일해 독소의 정제방법 및 이에 유용한 펩타이드
|
|
US20050147689A1
(en)
|
2003-12-30 |
2005-07-07 |
Egilmez Nejat K. |
Method for inhibiting the growth of gastrointestinal tract tumors
|
|
CA2558141C
(en)
|
2004-02-28 |
2012-03-06 |
Hemoteq Gmbh |
Biocompatible coating, method and use of medical surfaces
|
|
WO2005107795A1
(en)
|
2004-05-11 |
2005-11-17 |
Novo Nordisk Health Care Ag |
Use of factor viia for the treatment of burn traumas
|
|
US8728525B2
(en)
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
|
MXPA06012992A
(es)
|
2004-05-12 |
2007-02-12 |
Baxter Int |
Microesferas que comprenden proteina y que muestran inyectabilidad en altas concentraciones de este agente.
|
|
WO2005115442A1
(en)
|
2004-05-25 |
2005-12-08 |
Novo Nordisk Health Care Ag |
Use of coagulation factor xiii for treatment of post surgical bleedings
|
|
ES2399277T3
(es)
|
2004-05-27 |
2013-03-27 |
Baxter International Inc. |
Procedimiento de tratamiento de trastornos hemorrágicos utilizando polisacáridos sulfatados
|
|
EP1761630A2
(en)
|
2004-06-21 |
2007-03-14 |
Novo Nordisk Health Care AG |
Glycosylation-disrupted factor vii variants
|
|
US20090004175A1
(en)
|
2004-07-16 |
2009-01-01 |
Novo Nordick Health Care A/G |
Methods for Optimizing Forming Vlla-Based Hemostatic Treatment
|
|
US20060040896A1
(en)
|
2004-08-18 |
2006-02-23 |
Paringenix, Inc. |
Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
|
|
JP4252954B2
(ja)
|
2004-12-02 |
2009-04-08 |
インターナショナル・ビジネス・マシーンズ・コーポレーション |
情報処理装置、情報処理装置のパワーマネージメント方法、およびそのためのプログラム
|
|
EP1855712A2
(en)
|
2005-02-28 |
2007-11-21 |
Novo Nordisk Health Care AG |
Fxiii variants with improved properties
|
|
EP1869082B1
(en)
|
2005-03-04 |
2011-04-13 |
The Board Of Trustees Of The University Of Illinois |
Coagulation and fibrinolytic cascades modulator
|
|
EP1885335A1
(en)
|
2005-04-27 |
2008-02-13 |
BAXTER INTERNATIONAL INC. (a Delaware corporation) |
Surface-modified microparticles and methods of forming and using the same
|
|
KR20080008364A
(ko)
|
2005-05-05 |
2008-01-23 |
헤모텍 아게 |
관 스텐트의 전면 코팅
|
|
WO2006128497A1
(en)
|
2005-06-01 |
2006-12-07 |
Novo Nordisk A/S |
Pharmaceutical formulation of factor xi
|
|
EP1919499A2
(en)
|
2005-07-29 |
2008-05-14 |
Universiteit van Maastricht |
Regulation of tissue factor activity by protein s and tissue factor pathway inhibitor
|
|
DE102005039579B4
(de)
|
2005-08-19 |
2022-06-30 |
Magforce Ag |
Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen
|
|
GB0525999D0
(en)
|
2005-12-21 |
2006-02-01 |
Ares Trading Sa |
Novel members of the kazal family of serine protease inhibitors
|
|
EP1981559B1
(de)
|
2006-02-09 |
2016-11-23 |
B. Braun Melsungen AG |
Faltenballonbeschichtungsverfahren
|
|
US20070192033A1
(en)
|
2006-02-16 |
2007-08-16 |
Microsoft Corporation |
Molecular interaction predictors
|
|
WO2007127841A2
(en)
|
2006-04-26 |
2007-11-08 |
Arteriocyte Medical Systems, Inc. |
Compositions and methods of preparation thereof
|
|
US20070281031A1
(en)
|
2006-06-01 |
2007-12-06 |
Guohan Yang |
Microparticles and methods for production thereof
|
|
EP1892303A1
(en)
|
2006-08-22 |
2008-02-27 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Methods for identifying therapeutical targets in tumors and for determining and targeting angiogenesis and hemostasis related to adenocarcinomas of the lung
|
|
EP1895436A1
(en)
|
2006-08-31 |
2008-03-05 |
Silicos NV |
Method for evolving molecules and computer program for implementing the same
|
|
EP1913962A1
(en)
|
2006-10-22 |
2008-04-23 |
Ophir Perelson |
Expandable medical device for the treatment and prevention of cardiovascular diseases
|
|
JP5679663B2
(ja)
|
2007-02-23 |
2015-03-04 |
バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ |
海藻抽出物からのフコイダン精製のためのプロセスの方法
|
|
EP1972687A1
(en)
|
2007-03-23 |
2008-09-24 |
GenOdyssee |
Polynucleotides and polypeptides of human factor VII gene, SNPs
|
|
WO2008127654A2
(en)
|
2007-04-11 |
2008-10-23 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for intra-articular coagulation proteins
|
|
EP2915564B1
(en)
|
2007-09-28 |
2020-11-04 |
Portola Pharmaceuticals, Inc. |
Antidotes for factor XA inhibitors and methods of using the same
|
|
US20100297257A1
(en)
|
2007-11-09 |
2010-11-25 |
National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs) |
Anticoagulant antagonist and hemophillia procoagulant
|
|
CN101952309A
(zh)
|
2007-12-21 |
2011-01-19 |
Ifxa有限公司 |
蛋白酶抑制剂
|
|
FR2934052B1
(fr)
|
2008-07-17 |
2011-11-25 |
Stago Diagnostica |
Dosage de l'activite du facteur tissulaire circulant
|
|
UA112050C2
(uk)
|
2008-08-04 |
2016-07-25 |
БАЄР ХЕЛСКЕР ЛЛСі |
Терапевтична композиція, що містить моноклональне антитіло проти інгібітора шляху тканинного фактора (tfpi)
|
|
MX2011000847A
(es)
|
2008-08-06 |
2011-02-25 |
Novo Nordisk Healthcare Ag |
Proteinas conjugadas con eficacia prolongada in vivo.
|
|
KR100994996B1
(ko)
|
2008-08-06 |
2010-11-18 |
한국과학기술연구원 |
페난트렌 노출 여부 확인용 바이오마커 및 이를 이용한확인 방법
|
|
KR101792032B1
(ko)
*
|
2008-12-19 |
2017-11-02 |
백스터 인터내셔널 인코포레이티드 |
Ｔｆｐｉ 억제제 및 사용 방법
|
|
DK2547355T3
(en)
|
2010-03-19 |
2017-03-20 |
Baxalta GmbH |
TFPI INHIBITORS AND METHODS OF USE
|
|
MX2012013001A
(es)
|
2010-05-13 |
2013-02-26 |
Univ Indiana Res & Tech Corp |
Peptidos de la superfamilia de glucagon que presentan actividad del receptor nuclear de hormonas.
|
|
PL2694544T3
(pl)
|
2011-04-01 |
2019-07-31 |
Bayer Healthcare Llc |
Przeciwciała monoklonalne przeciwko inhibitorowi szlaku czynnika tkankowego (TFPI)
|
|
JP6153985B2
(ja)
|
2015-10-16 |
2017-06-28 |
株式会社スクウェア・エニックス |
ビデオゲーム処理プログラム、ビデオゲーム処理システム及びビデオゲーム処理方法
|